Home › Funds › BlackRock Inc › REGN
BlackRock Inc position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)9.11M sh
Reported value held$5.68B
Portfolio Weight0.09%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 8.48M | $8.91B | New |
| Q4 2024 | 8.73M | $6.22B | Add |
| Q1 2025 | 8.93M | $5.66B | Add |
| Q2 2025 | 9.28M | $4.87B | Add |
| Q3 2025 | 8.84M | $4.97B | Reduce |
| Q4 2025 | 8.74M | $6.75B | Reduce |
| Q1 2026 | 8.95M | $6.91B | Add |
| Q2 2026 | 9.11M | $5.68B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026